Fate Therapeutics
FATE
FATE
21 hedge funds and large institutions have $92.8M invested in Fate Therapeutics in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Holders
21
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$29.7M | |
| 2 | +$2.38M | |
| 3 | +$1.27M | |
| 4 |
Bank of New York Mellon
New York
|
+$374K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$233K |
Top Sellers
| 1 | -$2.62M | |
| 2 | -$740K | |
| 3 | -$165K | |
| 4 |
Goldman Sachs
New York
|
-$143K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$98.4K |